Samalin Investment Counsel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $352K | Sell |
905
-39
| -4% | -$15.2K | 0.14% | 229 |
|
|
2025
Q1 | $411K | Buy |
944
+115
| +14% | +$50.1K | 0.17% | 188 |
|
|
2024
Q4 | $306K | Sell |
829
-47
| -5% | -$17.4K | 0.13% | 219 |
|
|
2024
Q3 | $455K | Buy |
876
+2
| +0.2% | +$1.04K | 0.2% | 172 |
|
|
2024
Q2 | $474K | Buy |
874
+14
| +2% | +$7.6K | 0.22% | 149 |
|
|
2024
Q1 | $446K | Sell |
860
-225
| -21% | -$117K | 0.21% | 164 |
|
|
2023
Q4 | $512K | Buy |
1,085
+20
| +2% | +$9.44K | 0.26% | 125 |
|
|
2023
Q3 | $464K | Sell |
1,065
-12
| -1% | -$5.22K | 0.27% | 116 |
|
|
2023
Q2 | $479K | Buy |
1,077
+359
| +50% | +$160K | 0.26% | 121 |
|
|
2023
Q1 | $330K | Buy |
718
+4
| +0.6% | +$1.84K | 0.2% | 148 |
|
|
2022
Q4 | $366K | Hold |
714
| – | – | 0.23% | 130 |
|
|
2022
Q3 | $324K | Sell |
714
-30
| -4% | -$13.6K | 0.24% | 130 |
|
|
2022
Q2 | $359K | Hold |
744
| – | – | 0.25% | 124 |
|
|
2022
Q1 | $365K | Buy |
744
+191
| +35% | +$93.7K | 0.22% | 138 |
|
|
2021
Q4 | $257K | Buy |
+553
| New | +$257K | 0.15% | 194 |
|
|
2021
Q3 | – | Sell |
-540
| Closed | -$207K | – | 244 |
|
|
2021
Q2 | $207K | Buy |
+540
| New | +$207K | 0.13% | 223 |
|
|
2020
Q1 | – | Sell |
-370
| Closed | -$111K | – | 244 |
|
|
2019
Q4 | $111K | Buy |
+370
| New | +$111K | 0.09% | 211 |
|